Signal transduction by wild-type and leukemogenic Abl proteins
- PMID: 9426204
- DOI: 10.1016/s0304-419x(97)00023-1
Signal transduction by wild-type and leukemogenic Abl proteins
Similar articles
-
Biology of chronic myelogenous leukemia.Hematol Oncol Clin North Am. 1998 Feb;12(1):1-29. doi: 10.1016/s0889-8588(05)70495-0. Hematol Oncol Clin North Am. 1998. PMID: 9523224 Review.
-
Molecular biology of chronic myeloid leukemia.Int J Hematol. 2001 Apr;73(3):308-22. doi: 10.1007/BF02981955. Int J Hematol. 2001. PMID: 11345196 Review.
-
[The Philadelphia chromosome: from the gene to therapeutic methods].Sangre (Barc). 1998 Apr;43(2):127-35. Sangre (Barc). 1998. PMID: 9656774 Review. Spanish. No abstract available.
-
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.Oncogene. 1996 Feb 15;12(4):839-46. Oncogene. 1996. PMID: 8632906
-
Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.Oncogene. 1996 Jul 18;13(2):247-54. Oncogene. 1996. PMID: 8710363
Cited by
-
Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals.Mol Biol Cell. 2004 Aug;15(8):3520-9. doi: 10.1091/mbc.e04-02-0093. Epub 2004 May 21. Mol Biol Cell. 2004. PMID: 15155808 Free PMC article.
-
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.EMBO J. 2002 Nov 1;21(21):5766-74. doi: 10.1093/emboj/cdf562. EMBO J. 2002. PMID: 12411494 Free PMC article.
-
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.Pharmaceutics. 2022 Jan 17;14(1):215. doi: 10.3390/pharmaceutics14010215. Pharmaceutics. 2022. PMID: 35057108 Free PMC article. Review.
-
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.J Exp Med. 1999 Apr 19;189(8):1229-42. doi: 10.1084/jem.189.8.1229. J Exp Med. 1999. PMID: 10209040 Free PMC article.
-
Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis.Mol Cell Biol. 2002 Jun;22(12):4189-201. doi: 10.1128/MCB.22.12.4189-4201.2002. Mol Cell Biol. 2002. PMID: 12024032 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous